McDonald TJ - Search Results

1

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials.

Dawed AY, Mari A, Brown A, McDonald TJ, Li L, Wang S, Hong MG, Sharma S, Robertson NR, Mahajan A, Wang X, Walker M, Gough S, Hart LM', Zhou K, Forgie I, Ruetten H, Pavo I, Bhatnagar P, Jones AG, Pearson ER; DIRECT consortium. Dawed AY, et al. Among authors: mcdonald tj. Lancet Diabetes Endocrinol. 2023 Jan;11(1):33-41. doi: 10.1016/S2213-8587(22)00340-0. Lancet Diabetes Endocrinol. 2023. PMID: 36528349 Free article.

2

Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes.

McDonald TJ, Colclough K, Brown R, Shields B, Shepherd M, Bingley P, Williams A, Hattersley AT, Ellard S. McDonald TJ, et al. Diabet Med. 2011 Sep;28(9):1028-33. doi: 10.1111/j.1464-5491.2011.03287.x. Diabet Med. 2011. PMID: 21395678

3

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.

McDonald TJ, Shields BM, Lawry J, Owen KR, Gloyn AL, Ellard S, Hattersley AT. McDonald TJ, et al. Diabetes Care. 2011 Aug;34(8):1860-2. doi: 10.2337/dc11-0323. Epub 2011 Jun 23. Diabetes Care. 2011. PMID: 21700917 Free PMC article.

4

A novel case of a raised testosterone and LH in a young man.

McDonald TJ, Perry MH, Jones AG, Donohoe M, Salzmann MB, O'Connor J. McDonald TJ, et al. Clin Chim Acta. 2011 Oct 9;412(21-22):1999-2001. doi: 10.1016/j.cca.2011.06.028. Epub 2011 Jul 12. Clin Chim Acta. 2011. PMID: 21756889

5

Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.

Jones AG, Besser RE, McDonald TJ, Shields BM, Hope SV, Bowman P, Oram RA, Knight BA, Hattersley AT. Jones AG, et al. Among authors: mcdonald tj. Diabet Med. 2011 Sep;28(9):1034-8. doi: 10.1111/j.1464-5491.2011.03272.x. Diabet Med. 2011. PMID: 21843301

6

Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes.

Bowman P, McDonald TJ, Shields BM, Knight BA, Hattersley AT. Bowman P, et al. Among authors: mcdonald tj. Diabet Med. 2012 Jan;29(1):90-3. doi: 10.1111/j.1464-5491.2011.03428.x. Diabet Med. 2012. PMID: 21883437

7

The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.

Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, Hattersley AT. Shields BM, et al. Among authors: mcdonald tj. Diabetologia. 2012 May;55(5):1265-72. doi: 10.1007/s00125-011-2418-8. Epub 2012 Jan 5. Diabetologia. 2012. PMID: 22218698 Free PMC article.

8

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.

McDonald TJ, McEneny J, Pearson ER, Thanabalasingham G, Szopa M, Shields BM, Ellard S, Owen KR, Malecki MT, Hattersley AT, Young IS. McDonald TJ, et al. Clin Chim Acta. 2012 May 18;413(9-10):927-32. doi: 10.1016/j.cca.2012.02.005. Epub 2012 Feb 14. Clin Chim Acta. 2012. PMID: 22360925

9

The impact of insulin administration during the mixed meal tolerance test.

Besser RE, Jones AG, McDonald TJ, Shields BM, Knight BA, Hattersley AT. Besser RE, et al. Among authors: mcdonald tj. Diabet Med. 2012 Oct;29(10):1279-84. doi: 10.1111/j.1464-5491.2012.03649.x. Diabet Med. 2012. PMID: 22435709

10

Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.

Hope SV, Jones AG, Goodchild E, Shepherd M, Besser RE, Shields B, McDonald T, Knight BA, Hattersley A. Hope SV, et al. Diabet Med. 2013 Nov;30(11):1342-8. doi: 10.1111/dme.12222. Epub 2013 Jun 12. Diabet Med. 2013. PMID: 23659458 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

576 results

Search Page